Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients

INTRODCUTION: Through interaction with receptors TNFR1 and TNFR2, TNF-α activates a signal path, which exacerbates an inflammatory process, constituting an inseparable element of psoriasis. AIM: To evaluate changes in the expression of TNF-α, TNFR1, TNFR2 during the 4-year-long adalimumab therapy in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Postepy Dermatol Alergol
Autori principali: Wcisło-Dziadecka, Dominika, Grabarek, Beniamin, Kruszniewska-Rajs, Celina, Swinarew, Andrzej, Jasik, Krzysztof, Rozwadowska, Beata, Krawczyk, Agata
Natura: Artigo
Lingua:Inglês
Pubblicazione: Termedia Publishing House 2020
Soggetti:
Original Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675078/
https://ncbi.nlm.nih.gov/pubmed/33240014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2020.100484
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi